Clarity Medical Group Holding Limited disclosed that it allotted 3.43 million new ordinary shares on 3 July 2026 under its shareholder-approved Share Award Plan.
• Pre-issue share count: 536.33 million shares (as of 30 June 2026).
• New shares issued: 3.43 million, equal to 0.64% of the pre-existing share capital.
• Issue terms: Awarded shares granted to non-director participants; consideration per share stated as HKD 0.
• Post-issue share count: 539.77 million shares.
The filing confirms that the issuance was authorised by the board, complies with Hong Kong listing rules, and that no treasury shares were involved or repurchased during the period.
Comments